Navigation Links
Antares Pharma Announces Positive Results from Application Site,Study for Anturol

EWING, N.J.--(BUSINESS WIRE)--Apr 19, 2007 - Antares Pharma, Inc. (AMEX: AIS) announced positive results from a recently completed site application study demonstrating that ANTUROL(R), it's oxybutynin ATD(TM) transdermal gel, was absorbed on a bioequivalent basis after a single-dose was applied to three different skin site locations.

The study was an open-label, comparative three-way crossover, application site pharmacokinetic study. The trial enrolled 25 healthy subjects (80% women), aged 18 to 42, who received one dose of ANTUROL(R) applied topically on three skin sites: abdomen, thighs or shoulders alternatively with 10 days washout between doses. The results of the study were that each of the three sites evaluated delivered bioequivalent amounts of ANTUROL(R). Additionally, the ratio of plasma levels of R- to S- enantiomers of the active metabolite was lower following gel application (in comparison to higher a ratio of R- enantiomer levels known in oral products) indicating lower potential for adverse events from ANTUROL(R). Further, overall plasma levels of combined R- and S- enantiomers of the active metabolite were also lower in Anturol(R) in comparison to levels known in oral products.

Dario N. R. Carrara, Ph.D., SVP and Managing Director of the Pharmaceutical Group, commented, "We are pleased with the outcome of the study. The bioequivalence shown may allow patients to choose the most convenient site of application for ANTUROL(R) further enhancing the patient friendly benefits of our potential product. The ANTUROL Phase III protocol, will include a double blind, randomized, parallel, placebo controlled, multi-center study evaluating the effect of 12 weeks of treatment with ANTUROL(R) administered topically once daily to patients with urge and mixed urinary incontinence. We are diligently working on the ANTUROL(R) clinical program and we expect to announce the initiation of the Phase III trial sh
'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:8/21/2014)... Inc. (NASDAQ: CYBX ) today announced results for ... highlights 1   Operating results for the first ... fiscal 2014, and other achievements, include: , Worldwide net ... , Strong international net sales of $13.2 million, an increase ... net product sales reached a new high of $58.8 million, ...
(Date:8/21/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced positive results from a randomized, double-blind Phase ... for the treatment of edematous fibrosclerotic panniculopathy (EFP), ... trial, all three doses of CCH (low (0.06mg), ... in the appearance of cellulite as measured by ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 27, 2011   , Strategic ... rest of the world except Nordics and the US , ... US market , Photocure ASA (OSE: PHO), a ... cancer, announces today the execution of a new commercial strategy ...
... 2011 Women ages 65-69 who break a hip are five ... the same age who don,t break a hip, according to a ... Institutes of Health and published online today in the Archives ... death risk by age group. In addition to the finding for ...
Cached Medicine Technology:Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 2Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 3Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 4Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 5Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 6Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 7Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 8Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 2Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 3Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 4
(Date:8/21/2014)... Pulmonary Hypertension Association goes on ... for PH patients and families to help fight ... Association – the country’s leading pulmonary hypertension ... and cure pulmonary hypertension (PH) – a disease ... the heart and can lead right to heart ...
(Date:8/21/2014)... System and The University of Texas MD Anderson Cancer ... new level of specialized breast screening at a network ... area. , Starting in late November, MD Anderson will ... for five of Memorial Hermann,s 10 breast care centers, ... Sugar Land. , Over time, the network will expand ...
(Date:8/21/2014)... a low or very low birth weight may be ... The findings, which appear in Diabetes Care , ... 2 diabetes in African American populations, which has a ... Boston University,s Slone Epidemiology Center followed more than 21,000 ... the course of 16 years, analyzing characteristics such as ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Black mothers are less ... here,s one possible reason why: Hospitals in neighborhoods with ... those in areas with more white residents, a U.S. ... are much less common in medical centers where the ... U.S. Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... born at a low birth weight puts black women at ... The findings may partly explain high diabetes rates among ... low birth weight, the researchers added. Their study of ... low birth weight were 13 percent more likely to develop ... The risk of diabetes was 40 percent higher in those ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2
... quackery in the field of stem cell therapy, and propagate the ... work on improving the protocols involved in this therapy. // , ... The system would be developed under the leadership of director ... Union health secretary P K Hota., ,The decision comes as ...
... rather biological pacemaker by fusing connective tissue cells of ... pacemaker can fire on it’s own and regulate the ... way., ,Two sets of tiny electroactive 'pacing cells' ... by stimulating other cells to contract in certain sequences. ...
... of virginity affects men and women across the spectrum is included ... Sexual Experiences. This is the first book of its kind and ... most important events in life. We all read and hear the ... but it doesn't tell us what losing their virginity means to ...
... Vietnamese scientists have successfully decoded the gene of the deadly ... claimed.// If true, this news is really a shot in ... could herald in a better understanding of the variations and ... Ho Chi Minh City Pasteur Institute and the Regional Veterinary ...
... high fat, low carb diet promoted by the Harvard-trained diet ... could damage the heart., ,The study found the ... the heart's ability to store energy. , ,For the ... Research Group of Oxford University looked at 19 people who ...
... Jefferson researchers has found that kidney disease may be ... cholesterol. Studies conducted on mice have revealed that mice ... may also have high levels of a protein called ... ,A negative correlation was found between urinary albumin and ...
Cached Medicine News:Health News:Govt Keen To Propagate Stem Cell Research On Right Track 2Health News:Novel Biological Pacemaker Under Construction for Weak Hearts 2Health News:Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus 2Health News:Heart damage a consequence of Atkins’ Die 2
This catheter is intended for ultrasound examination of coronary intravascular pathology only. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
... is labeled with technetium 99m, MYOVIEW is ... regions of reversible myocardial ischemia in the ... and rest conditions. Imaging can begin as ... 4 hours after administration of MYOVIEW, enhancing ...
Universal Hub with Varying Blade Edge Diameters For Mounting the Blade to the Handle; Stainless Steel....
... Thallous Chloride Tl 201 Injection is supplied ... non-pyrogenic diagnostic radiopharmaceutical for intravenous administration. Each ... Chloride Tl 201 at calibration time, made ... preserved with 0.9% (v/v) benzyl alcohol. The ...
Medicine Products: